|
| Press Releases |
|
 |
|
| Wednesday, September 8, 2021 |
|
|
阿诺医药宣布AN2025、AN0025与atezolizumab三联治疗晚期实体瘤1a期临床在美国完成首例患者给药 |
阿诺医药，一家专注于肿瘤治疗领域的创新型全球生物制药公司，今日宣布其口服泛PI3K抑制剂buparlisib（AN2025）、口服EP4拮抗剂（AN0025）与PD-L1抑制剂atezolizumab（阿替利珠单抗）三联疗法在晚期/转移性实体瘤患者中开展的Ia期临床试验已于美国成功完成首例患者给药。
more info >> |
|
|
阿諾醫藥宣佈AN2025、AN0025與atezolizumab三聯治療晚期實體瘤1a期臨床在美國完成首例患者給藥 |
| 阿諾醫藥，一家專注於腫瘤治療領域的創新型全球生物製藥公司，今日宣佈其口服泛PI3K抑制劑buparlisib（AN2025）、口服EP4拮抗劑（AN0025）與PD-L1抑制劑atezolizumab（阿替利珠單抗）三聯療法在晚期/轉移性實體瘤患者中開展的Ia期臨床試驗已于美國成功完成首例患者給藥。 more info >> |
|
|
Adlai Nortye Announces First Patient Dosed in Phase Ia Clinical Trial of AN2025 and AN0025 in Combination with atezolizumab for Advanced Solid Tumors |
| Adlai Nortye, a global biopharmaceutical company focused on developing innovative oncology drugs, today announced that the first patient has been dosed in the Phase Ia clinical trial in the U.S. to evaluate the triple combination of AN2025 (buparlisib, oral pan-PI3K inhibitor), AN0025 (oral EP4 antagonist) and atezolizumab (PD-L1 inhibitor) in patients with locally advanced/metastatic tumors. more info >> |
|
| Thursday, July 15, 2021 |
|
|
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures |
| Adlai Nortye Ltd. (hereinafter referred to as "Adlai Nortye"), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
ANI.Finance, the Blockchain-to-Business DeFi Startup, Announces a Private Sale
May 24, 2022 00:00: JST
|
|
|
ANI.Finance, the Blockchain-to-Business DeFi Startup, Announces a Private Sale
May 24, 2022 00:00 HKT/SGT
|
|
|
Hektar REIT's NPI Goes up by 17.8% in 1Q 2022
May 23, 2022 22:00: JST
|
|
|
Malaysian Genomics Resource Centre Berhad Posts 212% Increase in Revenue for 3Q FY2022
May 23, 2022 22:00: JST
|
|
|
Hektar REIT's NPI Goes up by 17.8% in 1Q 2022
May 23, 2022 21:00 HKT/SGT
|
|
|
Malaysian Genomics Resource Centre Berhad Posts 212% Increase in Revenue for 3Q FY2022
May 23, 2022 21:00 HKT/SGT
|
|
|
医思健康收购连锁体检中心 进一步扩大客户基础整合健康检查市场
May 23, 2022 19:53 HKT/SGT
|
|
|
醫思健康收購連鎖體檢中心 進一步擴大客戶基礎整合健康檢查市場
May 23, 2022 19:52 HKT/SGT
|
|
|
EC Healthcare Acquires Health Screening Services Chain, Further Expand Customer Base and Consolidate the Health Screening Market
May 23, 2022 19:51 HKT/SGT
|
|
|
元宇宙GigaSpace与NFT平台UCOLLEX建立战略伙伴合作关系
May 23, 2022 18:26 HKT/SGT
|
|
|
元宇宙GigaSpace與NFT平台UCOLLEX建立戰略夥伴合作關係
May 23, 2022 18:25 HKT/SGT
|
|
|
Metaverse GigaSpace Forms Strategic Partnership with UCOLLEX
May 23, 2022 18:24 HKT/SGT
|
|
|
Dubai Grants Ex-Singapore Parliamentarian Calvin Cheng's Web3 Company a Virtual Asset License
May 23, 2022 17:47: JST
|
|
|
沛嘉医疗Tethys AS抽吸导管及Fastunnel输送型球囊扩张导管获NMPA批准上市
May 23, 2022 17:46 HKT/SGT
|
|
|
沛嘉醫療Tethys AS抽吸導管及Fastunnel輸送型球囊擴張導管獲NMPA批准上市
May 23, 2022 17:45 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
